<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01496950</url>
  </required_header>
  <id_info>
    <org_study_id>IIEP394-07</org_study_id>
    <nct_id>NCT01496950</nct_id>
  </id_info>
  <brief_title>Double-blind Randomized Clinical Trial of Transcranial Magnetic Stimulation in Chronic Migraine</brief_title>
  <acronym>TMS-CHROMIG</acronym>
  <official_title>Double-blind Randomized Clinical Trial to Evaluate Safety and Efficacy of Repetitive Transcranial Magnetic Stimulation in the Preventive Treatment of Chronic Migraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Israelita Albert Einstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Israelita Albert Einstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether active repetitive transcranial magnetic
      stimulation of the left dorsolateral prefrontal cortex is safe and effective for preventive
      treatment of chronic migraine, compared to placebo repetitive transcranial magnetic
      stimulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with chronic migraine according to the criteria of the International Headache
      Society will be randomized to either active repetitive transcranial magnetic stimulation of
      the left dorsolateral prefrontal cortex or placebo repetitive transcranial magnetic
      stimulation, in a total of 23 sessions of treatment (15 sessions in the first month and 8
      sessions in the second month of treatment). Outcomes will be evaluated at baseline, after
      one, two months after treatment, and one month after end of treatment
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of days with pain per month</measure>
    <time_frame>After all treatment sessions (total, 23 sessions within 60 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse effects</measure>
    <time_frame>After all treatment sessions (total, 23 sessions within 60 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Chronic Migraine</condition>
  <arm_group>
    <arm_group_label>Active Comparator: Active rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10Hz active rTMS delivered to the left dorsolateral prefrontal cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10Hz placebo rTMS delivered to the vertex</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>10Hz active rTMS</intervention_name>
    <description>10Hz active rTMS delivered to the left dorsolateral prefrontal cortex</description>
    <arm_group_label>Active Comparator: Active rTMS</arm_group_label>
    <other_name>Repetitive transcranial magnetic stimulation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>10Hz placebo rTMS delivered to the vertex</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Repetitive transcranial magnetic stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic migraine according to the criteria of the International Headache Society

          -  no change in prophylactic medication in the past 3 months

        Exclusion Criteria:

          -  other neurological disorders

          -  bipolar disorder

          -  alcohol or drug dependence in the past 2 months

          -  suicidal ideation, psychotic symptoms

          -  contraindications to transcranial magnetic stimulation (cardiac pacemaker, implanted
             electronic devices, metal in the skull, skull fractures, history of seizures)

          -  use of antidepressants in the past 4 weeks

          -  pregnancy or lack of birth-control method in women of childbearing age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adriana Conforto, MD,PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Israelita de Ensino e Pesquisa Albert Einstein</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Israelita de Ensino e Pesquisa Albert Einstein</name>
      <address>
        <city>São Paulo</city>
        <zip>05652901</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2011</study_first_submitted>
  <study_first_submitted_qc>December 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2011</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Israelita Albert Einstein</investigator_affiliation>
    <investigator_full_name>Adriana Conforto</investigator_full_name>
    <investigator_title>Professor of Neurology, MD PhD</investigator_title>
  </responsible_party>
  <keyword>migraine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

